Produktbild: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

169,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

14.03.2016

Abbildungen

XIV, 601 p. 100 illus., 50 illus. in color.

Herausgeber

Michael W. Jann + weitere

Verlag

Springer

Seitenzahl

601

Maße (L/B/H)

24,1/16/3,7 cm

Gewicht

1192 g

Auflage

1st ed. 2016

Sprache

Englisch

ISBN

978-3-319-27881-0

Beschreibung

Portrait


Michael
W. Jann, Pharm.D., FCP, FCCP is Professor and Chair for the Department of
Pharmacotherapy at the University of North Texas System College of Pharmacy
(UNTSCP) located at the UNT Health Sciences Center (UNTHSC). Professor Jann
received his Doctor of Pharmacy degree from the University of Southern California
and post-doctoral training in mental health pharmacy practice at the University
of Tennessee Memphis College of Pharmacy. He has published over 230 peer-review
articles, abstracts, and book chapters and served as a primary investigator for
numerous clinical trials in psychopharmacology. Professor Jann serves on the
editorial boards of six peer-review scientific journals including
CNS Drugs,
Molecular Diagnostics and Therapeutics, The Scientific World Journal –
Pharmacology Section, The Consultant Pharmacist, Journal of Clinical
Pharmacology,
and
Journal of Pharmacy Practice
.

Scott R. Penzak, Pharm.D., FCP, is Professor and
Vice Chair for the Departmentof Pharmacotherapy at the University of North
Texas System College of Pharmacy (UNTSCP) located at the UNT Health Sciences
Center (UNTHSC). Professor Penzak received his Doctor of Pharmacy degree from
Wayne State University and completed his post-doctoral training in infectious
diseases at the University of Arkansas for Medical Science (UAMS). Prior to
UNTSCP, he was the Director of the Clinical Pharmacokinetics Laboratory at the NIH.  He has published over 150 peer-review articles,
abstracts, and book chapters, and served as a principal investigator on
numerous pharmacokinetic and pharmacogeneticstudies. Professor Penzak serves on
the editorial boards of three peer-review scientific journals including
Journal
of Clinical Pharmacology, Pharmacotherapy,
and the
International Journal of
Pharmacokinetics.



Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP,
FCP, FNAP is currently Professor of Pharmacotherapy at the University of North
Texas System College of Pharmacy. Examples of Professor Cohen’s previous
service include, Global Director of CNS Research for Kendle International,
Director of the Office of Clinical Trials for University of Cincinnati, and
Director of Pharmaceutical Services for the Oklahoma Department of Mental
Health and Substance Abuse Services. Professor Cohen received his Doctor of Pharmacy
degree and post-doctoral training in psychiatric pharmacy from University of
Southern California School of Pharmacy. Professor Cohen has been a Board
Certified Psychiatry Pharmacist since the specialty was recognized. His relevant service on Editorial Boards include
Current
Psychiatry, Innovations in Clinical Neuroscience
, Primary Care Companion of the

Journal of Clinical Psychiatry, Drug Benefit Trends, Journal of the American
Medical Directors Association, CNS News
and
Pharmacy Practice News.



Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

14.03.2016

Abbildungen

XIV, 601 p. 100 illus., 50 illus. in color.

Herausgeber

Verlag

Springer

Seitenzahl

601

Maße (L/B/H)

24,1/16/3,7 cm

Gewicht

1192 g

Auflage

1st ed. 2016

Sprache

Englisch

ISBN

978-3-319-27881-0

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

  • Section 1. General Pharmacokinetic and Pharmacodynamic Principles of
    Psychopharmacological Agents.- 1. Pharmacokinetic Properties.- 2. Pharmacodynamic
    Properties.- 3. PET Scan and Other Biomarkers.- 4. Population
    Pharmacokinetics.- 5. Drug Transporters (esp. Blood Brain Barrier).- 6. Pharmacogenomics.-
    Section 2. Clinical Pharmacokinetics and Pharmacodynamics of
    Psychopharmacological Drug Classes.- 7. Antipsychotics – oral typical agents,
    oral atypical agents, and long-acting injectable (LAI) antipsychotics.- 8. Mood
    Stabilizers.- 9. Antidepressants – tricyclics, selective serotonergic reuptake
    inhibitors, serotonergic noradrenergic reuptake inhibitors, monoamine oxidase
    inhibitors, and other antidepressants.- 10. Benzodiazepines and Other Sedative
    Hypnotics/Anxiolytics.- 11. Opioid Analgesics.- 12. Stimulants and Other
    Non-Stimulants for ADHD.- 13. Cholinesterase Inhibitors and Other Antidementa
    Agents.- 14. Anti-Addiction Agents.- 15. Anesthetics.- Section 3. Clinically
    Significant Drug Interactions With Psychopharmacological Agents.- 16.
    Antipsychotics.- 17. Mood Stabilizers.- 18. Antidepressants.- 19.
    Benzodiazepines and Other Sedative Hypnotics/Anxiolytics.- 20. Opioid
    Analgesics.- 21. Stimulants and Other Non-Stimulants for ADHD.- 22. Cholinesterase
    Inhibitors and Other Antidementa Agents.- 23. Anti-Addiction Agents.- 24.
    Anesthetics.